Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × olaparib × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 25 Breast Neoplasms 16 Neoplasms 9 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Sarcoma 5 Pancreatic Neoplasms 5 Fanconi Anemia, Complementation Group D1 5 Endometrial Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Solid Tumor 1

Interventions

Gemcitabine 68 Cisplatin 49 pembrolizumab 29 Paclitaxel 26 Carboplatin 22 Docetaxel 19 Radiotherapy 16 atezolizumab 14 Doxorubicin 14 BCG Vaccine 14 Mitomycin 13 Nivolumab 11 Cystectomy 11 vinflunine 10 Methotrexate 10 Filgrastim 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Early Intervention, Educational 7 durvalumab 6 Taxes 6 Sunitinib 6 Methods 6 Cystoscopy 6 Albumin-Bound Paclitaxel 6 enfortumab vedotin 5 avelumab 5 Trastuzumab 5 Standard of Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03534492 2020-04-06

NEODURVARIB

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡